opioid crisis

a screensnap of Do No Harm trailer about doctor burnout

The panel will include a discussion with ‘Do No Harm’ documentary filmmaker Robyn Simon. Credit: Screen snap of film Do No Harm

By Jonah Comstock August 23, 2018
Eight years ago, Eliza CEO Alex Drane came up with the idea for “The Unmentionables,” an annual panel at Health 2.0 where participants would address difficult but important topics in healthcare. “Her bullet point was that there are things in healthcare that drive health outcomes that we don’t mention,” Health 2.0 cofounder and CEO Indu Subaiya told MobiHealthNews. “She started with topics like...
By Jonah Comstock April 26, 2018
This Saturday, the United States Drug Enforcement Agency (DEA) will host its third National Prescription Drug Take Back Day. And this time, Google is helping out.  The search engine company and tech giant announced in a blog post yesterday that it would implement several features to support the DEA's efforts to combat the opioid crisis, starting with a Google Maps-based locator tool to help...
By Laura Lovett January 5, 2018
Although generations of Americans have struggled with opioid addiction, what was once seen as a peripheral drug problem has lately hit the American public with force. Opioid overdoses have become so common that they are the number one cause of injury-related deaths in the United States, according to CDC reports. In 2015 alone opioids were involved in 33,091 deaths, according to the agency. The...
By Jonah Comstock December 11, 2017
Last week, the HHS' opioid crisis code-a-thon concluded with presentations by nine of the 50 teams that participated. Three of these teams were chosen as the competition's winners, and will receive $10,000 to further develop their ideas. “When the government holds a code-a-thon, there’s an admission in society that we have hit a roadblock, that we need help, and we go out to the polity to help us...
By Jonah Comstock October 18, 2017
Pear Therapeutics announced today that reSET-O, a digital therapeutic for opioid use disorder, has received an Expedited Access Pathway (EAP) designation from the FDA. The EAP designation doesn't mean that the FDA has cleared the product, only that it has committed to fast-tracking it through the clearance process because of its timely public health value.  “The opioid epidemic continues to...